CD14 and coronary artery disorder: According to the median distribution of the monocyte subsets, triple-vessel CAD was more common in patients with a lower percentage of classical CD14++CD16− monocytes (values below the median, Figure 3A) and with a higher percentage of non-classical CD14+CD16++ and intermediate CD14++CD16+ monocytes (Figure 3B,C).